Global daily deaths cross record
The number of reported global daily deaths from the coronavirus
stood at 10,816 on Tuesday, according to a Reuters tally, the
highest single-day death count.
The previous record of global daily deaths was 10,733, registered on
Nov. 4, according to the Reuters tally.
The United States, the worst-affected country worldwide, has
reported about 11.38 million infections and 248,574 deaths since the
pandemic started.
U.S. medical leaders rebuke Trump
The U.S. medical establishment on Tuesday urged President Donald
Trump to share critical COVID-19 data with President-elect Joe
Biden's team to avoid needless, deadly lags in tackling the
pandemic.

The extraordinary rebuke came in an open letter from three leading
healthcare organizations as state and local governments scrambled to
fight the virus in the absence of a coordinated national strategy.
"Real-time data and information on the supply of therapeutics,
testing supplies, personal protective equipment, ventilators,
hospital bed capacity and workforce availability to plan for further
deployment of the nation's assets needs to be shared to save
countless lives," said the letter, signed by heads of the American
Medical Association, the American Nurses Association and the
American Hospitals Association.
Sinovac's vaccine induces quick immune response
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered
a quick immune response but the level of antibodies produced was
lower than in people who had recovered from the disease, preliminary
trial results showed on Wednesday.
While the early to mid-stage trials were not designed to assess the
efficacy of CoronaVac, researchers said it could provide sufficient
protection, based on their experience with other vaccines and data
from preclinical studies with macaques.

[to top of second column] |

CoronaVac and four other experimental vaccines developed in China are currently
undergoing late-stage trials to determine their effectiveness.
'Highly contagious' outbreak in South Australia
South Australia on Wednesday declared a six-day lockdown to stamp out what the
state premier described as a highly contagious outbreak of the coronavirus
disease that officials linked to a returned traveller from Britain.
Most businesses will close, except for some food outlets, and people will be
largely confined to their homes as the state tries to avoid a more severe
breakout like the one that all but shuttered neighbouring Victoria for more than
100 days.
"We are going hard and we are going early. Time is of the essence and we must
act swiftly and decisively," South Australian Premier Steven Marshall said.
Infected Russian governor sparks anger
A Russian regional governor's decision to be treated for COVID-19 in a private
Moscow clinic rather than in his own region drew public criticism on Wednesday,
as Russia reported a new record daily high of 456 coronavirus-related deaths.

The disparity in healthcare provision between the Russian capital and other
regions is something that the Kremlin recognises. It has pumped extra resources
into the regions, some of which have complained of staff, equipment and bed
shortages, in an effort to narrow that gap.
Vladimir Sipyagin portrayed his decision as an altruistic one, saying he did not
want to deprive someone of a hospital bed in his own region, about 180
kilometres (112 miles) east of Moscow.
(Compiled by Linda Noakes; Editing by Alex Richardson)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |